Breast Cancer

EDU 60 - Treating Stage IV Breast Cancer: Who, What, Where and When?

Moderator(s)

• 

  Julie Choi, MD

  Columbia Pre
  Bronxville, NY

The session will be opened by Dr. Choi who will discuss the incidence of Stage IV breast cancer. They will also discuss treatment trends and disparities among minority groups in this patient population. Next, Dr. Eileen Connolly will discuss the results of BR002 and CURB to give a brief review, including the limitations, of the randomized data around the oligometastatic population. She will also discuss some of the retrospective data that encourages oligometastatic treatment, helping to model a nuanced approach to this very heterogeneous patient population. Next, Dr. Seema Khan, will comprehensively review the literature for primary breast treatment in the context of metastatic disease, including the results of the trial for which she was PI, EA2108.
Next, Dr. Michael Yan will offer his take on how to practically approach treatment of the primary in stage IV patients, and how to incorporate response to systemic therapy and extent of oligometastases in the shared decision making process with the patient. He will also discuss the field and fractionation options available to us.

Presentations:

• 5:15 PM – 5:17 PM ET

  Introductions
  

  Speaker: Julie Choi, MD – Columbia Pre
• 5:15 PM – 5:17 PM ET

  Introductions
  

  Speaker: Julie Choi, MD – Columbia Pre
• 5:17 PM – 5:32 PM ET

  Primary Source - Treating the Primary in Stage IV Patients
  

  Speaker: Seema Khan, MD – Northwestern University
• 5:32 PM – 5:47 PM ET

  One Too Many? - What We Know so Far about Oligometastatic Breast Cancer
  

  Speaker: Eileen Connolly, MD, PhD – Columbia University Irving Medical Center
• 5:47 PM – 6:02 PM ET

  Dealers Choice - Knowing When to Treat
  

  Speaker: Michael Yan, MD – Princess Margaret Cancer Center, University Health Network
• 6:02 PM – 6:15 PM ET

  Questions and Answers
  

  Speaker: Julie Choi, MD – Columbia Pre